United Kingdom (UK) Generics Market Summary, Competitive Analysis and Forecast, 2017-2026
![](/report_cover/4228/united-kingdom-uk-generics-market-summary-competitive-analysis-n-forecast-2017-2026_en.gif)
United Kingdom (UK) Generics Market @Summary, Competitive Analysis and Forecast, 2017-2026
SUMMARY
Generics in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
SUMMARY
Generics in the United Kingdom industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
KEY HIGHLIGHTS
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The UK generics market had total revenues of $15.9bn in 2021, representing a compound annual growth rate (CAGR) of 6.4% between 2016 and 2021.
- Market consumption volume increased with a CAGR of 1.8% between 2016 and 2021, to reach a total of 88.2 % in 2021.
- Over the past five years, the UK market recorded growth of 7.4%. Growth in the market has been driven by population aging as well as government efforts to lower the cost of healthcare.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in the United Kingdom
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in the United Kingdom
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United Kingdom generics market with five year forecasts
- What was the size of the United Kingdom generics market by value in 2021?
- What will be the size of the United Kingdom generics market in 2026?
- What factors are affecting the strength of competition in the United Kingdom generics market?
- How has the market performed over the last five years?
- What are the main segments that make up the United Kingdom's generics market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How did the COVID-19 pandemic impact leading players?
8 COMPANY PROFILES
8.1. Teva Pharmaceutical Industries Limited
8.2. Viatris Inc.
8.3. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How did the COVID-19 pandemic impact leading players?
8 COMPANY PROFILES
8.1. Teva Pharmaceutical Industries Limited
8.2. Viatris Inc.
8.3. Pfizer Inc.
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: United Kingdom generics market value: $ billion, 2016-21
Table 2: United Kingdom generics market volume: %, 2016-21
Table 3: United Kingdom generics market geography segmentation: $ billion, 2021
Table 4: United Kingdom generics market value forecast: $ billion, 2021-26
Table 5: United Kingdom generics market volume forecast: %, 2021-26
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Viatris Inc.: key facts
Table 10: Viatris Inc.: Annual Financial Ratios
Table 11: Viatris Inc.: Key Employees
Table 12: Viatris Inc.: Key Employees Continued
Table 17: Pfizer Inc.: key facts
Table 18: Pfizer Inc.: Annual Financial Ratios
Table 19: Pfizer Inc.: Key Employees
Table 20: Pfizer Inc.: Key Employees Continued
Table 21: United Kingdom size of population (million), 2017-21
Table 22: United Kingdom gdp (constant 2005 prices, $ billion), 2017-21
Table 23: United Kingdom gdp (current prices, $ billion), 2017-21
Table 24: United Kingdom inflation, 2017-21
Table 25: United Kingdom consumer price index (absolute), 2017-21
Table 26: United Kingdom exchange rate, 2017-21
Table 1: United Kingdom generics market value: $ billion, 2016-21
Table 2: United Kingdom generics market volume: %, 2016-21
Table 3: United Kingdom generics market geography segmentation: $ billion, 2021
Table 4: United Kingdom generics market value forecast: $ billion, 2021-26
Table 5: United Kingdom generics market volume forecast: %, 2021-26
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Viatris Inc.: key facts
Table 10: Viatris Inc.: Annual Financial Ratios
Table 11: Viatris Inc.: Key Employees
Table 12: Viatris Inc.: Key Employees Continued
Table 17: Pfizer Inc.: key facts
Table 18: Pfizer Inc.: Annual Financial Ratios
Table 19: Pfizer Inc.: Key Employees
Table 20: Pfizer Inc.: Key Employees Continued
Table 21: United Kingdom size of population (million), 2017-21
Table 22: United Kingdom gdp (constant 2005 prices, $ billion), 2017-21
Table 23: United Kingdom gdp (current prices, $ billion), 2017-21
Table 24: United Kingdom inflation, 2017-21
Table 25: United Kingdom consumer price index (absolute), 2017-21
Table 26: United Kingdom exchange rate, 2017-21
LIST OF FIGURES
Figure 1: United Kingdom generics market value: $ billion, 2016-21
Figure 2: United Kingdom generics market volume: %, 2016-21
Figure 3: United Kingdom generics market geography segmentation: % share, by value, 2021
Figure 4: United Kingdom generics market value forecast: $ billion, 2021-26
Figure 5: United Kingdom generics market volume forecast: %, 2021-26
Figure 6: Forces driving competition in the generics market in the United Kingdom, 2021
Figure 7: Drivers of buyer power in the generics market in the United Kingdom, 2021
Figure 8: Drivers of supplier power in the generics market in the United Kingdom, 2021
Figure 9: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2021
Figure 10: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2021
Figure 11: Drivers of degree of rivalry in the generics market in the United Kingdom, 2021
Figure 1: United Kingdom generics market value: $ billion, 2016-21
Figure 2: United Kingdom generics market volume: %, 2016-21
Figure 3: United Kingdom generics market geography segmentation: % share, by value, 2021
Figure 4: United Kingdom generics market value forecast: $ billion, 2021-26
Figure 5: United Kingdom generics market volume forecast: %, 2021-26
Figure 6: Forces driving competition in the generics market in the United Kingdom, 2021
Figure 7: Drivers of buyer power in the generics market in the United Kingdom, 2021
Figure 8: Drivers of supplier power in the generics market in the United Kingdom, 2021
Figure 9: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2021
Figure 10: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2021
Figure 11: Drivers of degree of rivalry in the generics market in the United Kingdom, 2021